Natural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/JAK2/STAT3 signal pathway

In conclusion, our current study indicated that Byakangelicin, a natural compound, inhibits SHP-1/JAK2/STAT3 signaling and thus blocks tumor growth and motility.PMID:38484571 | DOI:10.1016/j.bbrc.2024.149758

Source: Biochemical and Biophysical Research communications - March 14, 2024 Category: Biochemistry Authors: Xiuzhen Shi Yuexing Lai Wenjing Liu Xi Zhang Yanqin Cang Source Type: research